Biotech

All Articles

Praxis epilepsy medication reduces seizures in period 2 litigation

.Praxis Preciseness Medicines has scored another midphase succeed in epilepsy this year, with its sa...

Three officers resign as Dyne blog posts combined data for DMD applicant

.After getting away a scientific hold a number of years back, Dyne Rehab has actually revealed brand...

Arrowhead fires off period 3 information in uncommon metabolic disease before market clash with Ionis

.Arrowhead Pharmaceuticals has shown its give in front of a prospective showdown with Ionis, releasi...

Pfizer, Valneva show lyme ailment chance effective for 2nd booster

.Pfizer and also Valneva may have regarding two additional years to wait prior to they help make the...

Fierce Biotech Managing Editor Ayla Ellison Talks Patronize Michelle Benz on the Future of Biotech.

.Let's study a conversation with Ayla Ellison, Brutal Biotech Managing Editor and Michelle Benz as t...

New records demonstrate how Bayer's asundexian neglected to avoid strokes

.Bayer put on hold the phase 3 trial for its variable XIa prevention asundexian late in 2014 after t...

Sanofi's tolebrutinib neglects 2 of 3 late-stage MS trials

.Sanofi is still bented on taking its several sclerosis (MS) med tolebrutinib to the FDA, execs have...

Galapagos' stock up as fund presents intent to shape its development

.Galapagos is happening under extra pressure from entrepreneurs. Having built a 9.9% risk in Galapag...

Cell- concentrated Sana scoops 1st CSO-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of substantial management hirings, firings and r...

Allist settles Jacobio $21M, landing task in Chinese KRAS ethnicity

.Shanghai Allist Pharmaceuticals has bought on its own a starring character in China's KRAS market, ...